Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study

2018 ◽  
Vol 34 (2) ◽  
pp. 364-369 ◽  
Author(s):  
Masanori Atsukawa ◽  
Akihito Tsubota ◽  
Hidenori Toyoda ◽  
Koichi Takaguchi ◽  
Chisa Kondo ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Chronic Hepatitis C ◽  
Multicenter Study ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Post Hoc Analysis ◽  
Post Hoc

The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease

2020 ◽  
Author(s):  
Ahmed Yahia Elmowafy ◽  
Mohamed Hamed Abbas ◽  
Ahmed Abdelfattah Denewar ◽  
Mohamed Elsayed Mashaly ◽  
Gamal Shiha ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Chronic Hepatitis C ◽  
Efficacy And Safety ◽  
Direct Acting Antivirals ◽  
Hepatitis C Infection ◽  
Direct Acting

Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease

2018 ◽  
Vol 48 (7) ◽  
pp. 549-555 ◽  
Author(s):  
Taeang Arai ◽  
Masanori Atsukawa ◽  
Akihito Tsubota ◽  
Tadashi Ikegami ◽  
Noritomo Shimada ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Combination Therapy ◽  
Chronic Hepatitis C ◽  
Efficacy And Safety ◽  
Genotype 1B ◽  
Chronic Hepatitis C Patients

Efficacy and safety of antiviral therapy with glecaprevir+ pibrentasvir for patients with chronic hepatitis c and chronic kidney disease

Nephrology ◽  
2018 ◽  
Vol 4_2018 ◽  
pp. 55-61
Author(s):  
E.A. Strebkova Strebkova ◽  
O.V. Agafonova Agafonova ◽  
E.S. Kindalova Kindalova ◽  
V.P. Varkentin Varkentin ◽  
A.M. Kalyshenko Kalyshenko ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Antiviral Therapy ◽  
Chronic Hepatitis C ◽  
Efficacy And Safety

scholarly journals Efficacy and safety of elbasvir and grazoprevir for chronic hepatitis C patients with chronic kidney disease

Kanzo ◽  
2017 ◽  
Vol 58 (12) ◽  
pp. 678-680
Author(s):  
Masanori Atsukawa ◽  
Hidenori Toyoda ◽  
Koichi Takaguchi ◽  
Noritomo Shimada ◽  
Hiroshi Abe ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Chronic Hepatitis C ◽  
Efficacy And Safety ◽  
Chronic Hepatitis C Patients

scholarly journals Efficacy and safety of ombitasvir/paritaprevir/ritonavir/ribavirin in management of Egyptian chronic hepatitis C virus patients with chronic kidney disease

Medicine ◽  
2020 ◽  
Vol 99 (42) ◽  
pp. e21972
Author(s):  
Sherief Abd-Elsalam ◽  
Yousry Esam-Eldin Abo-Amer ◽  
Mohamed El-Abgeegy ◽  
Samah A. Elshweikh ◽  
Heba Fadl Elsergany ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Chronic Hepatitis C ◽  
Efficacy And Safety ◽  
Chronic Hepatitis C Virus

Therapy with DAAs in patients with chronic hepatitis C and advanced chronic kidney disease: Real-world experience of the German Hepatitis C Registry

2018 ◽  
Vol 56 (01) ◽  
pp. E2-E89
Author(s):  
J Wiegand ◽  
P Buggisch ◽  
S Mauss ◽  
K Böker ◽  
H Klinker ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Chronic Hepatitis C ◽  
Real World ◽  
Advanced Chronic Kidney Disease

Usefulness of combination therapy with Daclatasvir plus Asunaprevir in chronic hepatitis C patients with chronic kidney disease

2016 ◽  
Vol 21 (5) ◽  
pp. 818-824 ◽  
Author(s):  
Norihiko Morisawa ◽  
Yohei Koshima ◽  
Jun-ichi Satoh ◽  
Yukio Maruyama ◽  
Satoru Kuriyama ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Combination Therapy ◽  
Chronic Hepatitis C ◽  
Chronic Hepatitis C Patients

scholarly journals Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD

Hepatology ◽  
2017 ◽  
Vol 67 (2) ◽  
pp. 492-504 ◽  
Author(s):  
Haesuk Park ◽  
Chao Chen ◽  
Wei Wang ◽  
Linda Henry ◽  
Robert L. Cook ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Chronic Hepatitis C ◽  
Hcv Treatment ◽  
Chronic Hepatitis C Virus ◽  
Incidence Of Ckd

Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real-world cohort study focusing on chronic kidney disease

2018 ◽  
Vol 159 ◽  
pp. 143-152 ◽  
Author(s):  
Eiichi Ogawa ◽  
Norihiro Furusyo ◽  
Koichi Azuma ◽  
Makoto Nakamuta ◽  
Hideyuki Nomura ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Chronic Hepatitis ◽  
Cohort Study ◽  
Hepatitis C ◽  
Kidney Disease ◽  
Chronic Hepatitis C ◽  
Real World ◽  
Genotype 1
Sign in / Sign up

Export Citation Format

Share Document